Attention Deficit Disorder (ADHD)



Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Adaptive Inhibitory Control Training;   Behavioral: Non-adaptive Inhibitory Control Training
Sponsors:   Boston Children’s Hospital;   Neuroscouting, L.L.C.
Completed


Group Dialectical Behavior Therapy as add-on Treatment for Adults With Attention Deficit/Hyperactive Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Skill Training Group of the Dialectical Behavior Therapy;   Other: Treatment as Usual
Sponsor:   Hospital de Clinicas de Porto Alegre
Not yet recruiting


Effects of Polyunsaturated Fatty Acids on the Visual Memory of Children With Attention Deficit Hyperactivity Disorder


Condition:   Attention-deficit/Hyperactivity Disorder
Intervention:  
Sponsor:   National Taiwan University Hospital
Recruiting


NEUROFEEDBACK on Event-Related Potential (ERP)


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Other: Neurofeedback training;   Other: Active Sham control;   Other: Baseline control group
Sponsor:   Hospices Civils de Lyon
Recruiting


Long-term Effects of Medication for ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   Göteborg University
Recruiting


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline;   Drug: Placebo
Sponsor:   Sunovion
Recruiting


Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate LA (Ritalin);   Drug: Mixed Amphetamine Salts XR (Adderall)
Sponsors:   Massachusetts General Hospital;   Massachusetts Institute of Technology
Not yet recruiting


Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: NFC-1 100 mg;   Drug: NFC-1 200 mg;   Drug: NFC-1 400 mg;   Drug: NFC-1 800 mg
Sponsor:   Aevi Genomic Medicine
Completed


The Effects of Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder


Conditions:   Attention Deficit Disorder With Hyperactivity;   Psychophysiology
Interventions:   Other: Working memory training;   Other: perceptual training
Sponsor:   Chang Gung Memorial Hospital
Completed


Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: cognitive behavior group therapy;   Other: Treatment as usual
Sponsors:   St. Olavs Hospital;   Norwegian University of Science and Technology
Recruiting


Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Behavioral: Cognitive-behavioral therapy
Sponsor:   Karolinska Institutet
Completed


Software Treatment for Actively Reducing Severity of ADHD - Follow Up


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Device: EVO
Sponsor:   Akili Interactive Labs, Inc.
Active, not recruiting


A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   Aevi Genomic Medicine
Completed


Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: mazindol
Sponsor:   NLS-1 Pharma Inc.
Completed


Early Interventions in Children With Attention Deficit/Hyperactivity Disorder


Conditions:   Attention Deficit Disorder With Hyperactivity;   Preschool Child
Interventions:   Drug: Methylphenidate;   Behavioral: Parental training;   Other: Psychoeducational groups for parents;   Drug: Placebo pill
Sponsors:   University of Sao Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting


Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit-Hyperactivity Disorder
Interventions:   Device: Neurofeedback NFT;   Drug: Methylphenidate MPH
Sponsors:   Mensia Technologies SA;   European Union H2020 SME Instrument
Recruiting


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline 4mg;   Other: Placebo
Sponsor:   Sunovion
Completed


Software Treatment for Actively Reducing Severity of ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Device: EVO
Sponsor:   Akili Interactive Labs, Inc.
Active, not recruiting


Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Methylphenidate (MPH);   Drug: Atomoxetine
Sponsor:   Asan Medical Center
Recruiting


Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity


Condition:   Attention-Deficit/Hyperactivity Disorder
Intervention:   Other: Neuropsychological tests
Sponsor:   University Hospital, Bordeaux
Completed


Genetic, Brain Structure, and Environmental Effects on ADHD


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting


Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits


Conditions:   Traumatic Brain Injury;   Attention Deficit Disorder
Interventions:   Drug: Vyvanse;   Procedure: fMRI;   Drug: Placebo
Sponsors:   Vanderbilt University;   Shire
Terminated


Reducing Attention Deficit Hyperactivity Disorder in Kindergarten and Pre-Kindergarten Children


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: Friendship Group;   Behavioral: Academic tutoring
Sponsors:   Penn State University;   National Institute of Mental Health (NIMH)
Completed


Treatment of Patients With Alcoholism and Attention Deficit Disorder


Conditions:   Alcoholism;   Attention Deficit Disorder
Intervention:   Drug: Methylphenidate
Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed


Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Active, not recruiting

Refine Your Search Advanced Search